S. Murugapandian, “Effectiveness of Casirivimab-Imdevimab and Sotrovimab Monoclonal Antibody Treatment among High-Risk Patients with Sars-Cov-2 Infection: A Real-World Experience”, acbr, vol. 7, no. 3, pp. 325–336, May 2023.